CNCE - Concert Pharma Q3 2022 Earnings Preview
- Concert Pharma ( NASDAQ: CNCE ) is scheduled to announce Q3 earnings results on Monday, November 7th, before market open.
- The consensus EPS Estimate is -$0.59 and the consensus Revenue Estimate is $0.08M (-84.0% Y/Y).
- Over the last 3 months, EPS estimates have seen 4 upward revisions and 0 downward.
For further details see:
Concert Pharma Q3 2022 Earnings Preview